Financhill
Sell
45

GPCR Quote, Financials, Valuation and Earnings

Last price:
$70.05
Seasonality move :
-4.5%
Day range:
$71.81 - $77.35
52-week range:
$13.22 - $94.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.61x
Volume:
874K
Avg. volume:
1.1M
1-year change:
196.1%
Market cap:
$5.1B
Revenue:
--
EPS (TTM):
-$3.65

Earnings Data

Next earnings date for GPCR
Feb 26
2026
Most recent earnings per share
-$1.13
Missed by $0.70
(Nov 6/2025)
Consensus Estimate
-$0.43
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GPCR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -$0.36 --
02/26/2026 Q4 -- -- -- -$0.36 --
11/06/2025 Q3 -- -- -$1.13 -$0.43 -$0.70
08/08/2025 Q2 -- -- -$1.08 -$0.36 -$0.71
05/08/2025 Q1 -- -- -$0.82 -$0.23 -$0.59
02/27/2025 Q4 -- -- -$0.63 -$0.17 -$0.47
11/13/2024 Q3 -- -- -$0.60 -$0.19 -$0.41
08/08/2024 Q2 -- -- -$0.53 -$0.23 -$0.30
05/09/2024 Q1 -- -- -$0.56 -$0.22 -$0.34
03/08/2024 Q4 -- -- -$0.53 -$0.21 -$0.32
11/17/2023 Q3 -- -- -$0.62 -- --
08/10/2023 Q2 -- -- -$0.60 -- --
05/11/2023 Q1 -- -- -$0.75 -- --
12/31/2022 Q4 -- -- -$0.32 -- --
09/30/2022 Q3 -- -- -$0.49 -- --
06/30/2022 Q2 -- -- -$0.42 -- --
03/31/2022 Q1 -- -- -$0.36 -- --
12/31/2021 Q4 -- -- -$0.42 -- --

Structure Therapeutics, Inc. Earnings Questions

  • How Much did Structure Therapeutics, Inc. Generate in Revenue Last Quarter?

    Structure Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Structure Therapeutics, Inc. Beat Earnings Last Quarter?

    Structure Therapeutics, Inc. announced earnings per share of -$1.13 which represents a miss of analyst forecast a -$0.43 per share.

  • Is Structure Therapeutics, Inc. Profitable?

    Structure Therapeutics, Inc. reported -$978.3K that represents -$0.02 per share over the last quarter.

  • What is the Analyst Consensus for Structure Therapeutics, Inc. EPS Next Year?

    Structure Therapeutics, Inc.'s earnings are forecast to decrease from -$2.33 per share to -$1.35 per share next year representing a decrease of -45.74%.

  • When is Structure Therapeutics, Inc.'s Earnings Date?

    Structure Therapeutics, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 64x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 35x

Sell
42
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 29x

Alerts

Sell
17
ICLR alert for Feb 13

ICON plc [ICLR] is up 15.9% over the past day.

Buy
67
CGNX alert for Feb 13

Cognex Corp. [CGNX] is up 0.31% over the past day.

Buy
77
IPGP alert for Feb 13

IPG Photonics Corp. [IPGP] is up 2.47% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock